For the press


  1. Model can predict success of treatments that manipulate the gut microbiota

    Researchers present new model that "can be considered a stepping stone to the development and rational design of microbiome therapies".
  2. Scientists identify potential targets for new autoimmune disease treatments

    New findings could have implications for the development of treatments for conditions where the body is attacked by the immune system.
  3. Media coverage: March roundup of eLife papers in the news

    High-profile news coverage that eLife papers generated in March 2018, including the Los Angeles Times, Discover and Forbes.
  4. Jeff Settleman joins eLife as a Senior Editor

    Calico’s leading oncologist will help non-profit journal serve frontline cancer research.
  5. Gut environment protects microbes from dietary factors that usually harm them

    New findings have important implications for understanding the influence of dietary factors on the makeup of our healthy gut microbiome.
  6. Media coverage: February roundup of eLife papers in the news

    High-profile news coverage that eLife papers generated in February 2018, including The Atlantic, Nature and The Scientist.
  7. Study reveals how forager ants keep their colonies well fed

    New research shows how ants can adjust their foraging activities according to their colony’s overall hunger level, without knowing explicitly what this is.
  8. eLife welcomes Anna Akhmanova as new Deputy Editor

    Akhmanova takes over from Fiona Watt as eLife’s third Deputy Editor.
  9. eLife showcases important advances in Physics of Living Systems

    eLife's new subject area highlights leading research at the interface between the physical and life sciences.
  10. New insight on malaria parasite transmission could inform future drug development

    Newly published clinical trial results suggest an established model for studying malaria could be used to evaluate interventions that block parasite transmission.

Enquiries about published papers, material in press and eLife may be directed to, or +44 1223 855373.

If you’re writing about an eLife study, please cite eLife as the source of the article and include a link to either the article or, preferably using our DOI: – with the article’s five-digit extension (e.g. Thank you!

All content, unless otherwise stated, is available under a Creative Commons Attribution License (CC-BY). All are free to use and reuse the content provided the original source and authors are credited.

The eLife media policy, encouraging authors to present and discuss their works ahead of publication and indicating that eLife will not release content under embargo, can be found under the Media Policy heading in our Journal Policies.

Please don’t hesitate to contact us if you have any questions.